What do you work on and why is your research important?
I work on elucidating the mechanisms of action of drug molecules, by chemically altering them and studying them in cells. Furthermore, my work encompasses the study of Cancer Stem Cells and how to target them specifically, to develop novel anti-cancer strategies. I have also studied the dynamics of specialised chromatin domains, centromeres, to understand the underlying mechanisms of their formation and how things can go awry during the cell cycle and in disease. This is important to develop novel therapeutic strategies to target cancers that are hard to treat, in particular metastases.
What is special about your former institute?
The University of Cambridge is one of the forerunners of academic teaching and research in the world. I loved the scientific exchange that occurs a the university and in the city on a continuous basis.
What is special and what do you like most about your current institute?
The Curie Institute is one of the leading cancer institutes in the world, with strong ties to its hospital.
What have you gained from moving within Europe?
The cultural and scientific richness that one gains by moving between countries is invaluable. Not only do I now speak three languages fluently, but I have worked with outstanding scientists from all over Europe and the world.
What is the added value of eulife?
Networking between top institutes and learning about how research is conducted at these institutes and in their respective countries. It also facilitates collaborations, which may prove useful in the future.
If only I know then what I know now, I would advise...
Be bold and go where nobody has ever gone before.